Alkermes plc. Segment Reporting Other Item Amount
Alkermes plc. (ALKS) reported Segment Reporting Other Item Amount of $66.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-07-28
- Alkermes plc. segment reporting other item amount for the quarter ending 2026-06-30 was $66.85M, a 1036.92% increase year-over-year.
- Alkermes plc. segment reporting other item amount for the quarter ending 2026-03-31 was $29.88M.
- Alkermes plc. segment reporting other item amount for the quarter ending 2025-12-31 was $8.76M, a 48.35% decline year-over-year.
- Alkermes plc. segment reporting other item amount for the quarter ending 2025-09-30 was $6.32M, a 47.22% decline year-over-year.
- Alkermes plc. segment reporting other item amount for fiscal 2025 was $12.29M, a 75.22% decline from fiscal 2024.
- Alkermes plc. segment reporting other item amount for fiscal 2024 was $49.60M.
- Alkermes plc. segment reporting other item amount for fiscal 2023 was -$69.35M, a 209.33% decline from fiscal 2022.
- Alkermes plc. segment reporting other item amount for fiscal 2022 was $63.43M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $66.85M 10-Q · filed 2026-07-28 | $96.73M 10-Q · filed 2026-07-28 | $105.49M derived: sum of 3 quarters · filed 2026-07-28 | $111.81M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $29.88M 10-Q · filed 2026-05-05 | $38.64M derived: sum of 2 quarters · filed 2026-05-05 | $44.96M derived: sum of 3 quarters · filed 2026-05-05 | $50.84M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.08M derived: sum of 2 quarters · filed 2026-02-25 | $20.96M derived: sum of 3 quarters · filed 2026-07-28 | $12.29M 10-K · filed 2026-02-25 |
| 2025-09-30 | $6.32M 10-Q · filed 2025-10-28 | $12.20M derived: sum of 2 quarters · filed 2026-07-28 | $3.53M 10-Q · filed 2025-10-28 | $20.49M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $5.88M 10-Q · filed 2026-07-28 | -$2.79M 10-Q · filed 2026-07-28 | $14.17M derived: sum of 3 quarters · filed 2026-07-28 | $26.15M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | -$8.67M 10-Q · filed 2026-05-05 | $8.29M derived: sum of 2 quarters · filed 2026-05-05 | $20.27M derived: sum of 3 quarters · filed 2026-05-05 | $35.51M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $28.94M derived: sum of 2 quarters · filed 2026-02-25 | $44.18M derived: sum of 3 quarters · filed 2026-02-25 | $49.60M 10-K · filed 2026-02-25 |
| 2024-09-30 | $11.97M 10-Q · filed 2025-10-28 | $27.21M derived: sum of 2 quarters · filed 2025-10-28 | $32.63M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $15.24M 10-Q · filed 2025-07-29 | $20.66M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $5.42M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$69.35M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $63.43M 10-K · filed 2025-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |